• Accueil
• support à infusion
• Treatment support for CINQAIR® (reslizumab) Injection patients

Treatment support for CINQAIR® (reslizumab) Injection patients

4.9 (500) · € 27.50 · En Stock

CINQAIR® (reslizumab) Injection – About CINQAIR

Reslizumab - CINQAIR - Asthma & Allergy Foundation of America

Reslizumab (Cinqair) - Uses, Dose, Side effects

Effect of fixed-dose subcutaneous reslizumab on asthma

Biologic Therapy for Eosinophilic Asthma

Biologics for the Treatment of Asthma

Teva's Asthma Therapy Reslizumab Fails in Late-Stage Studies

Treating Severe Asthma

Dosing and Administration

FDA approves Teva's Cinqair (reslizumab) Injection

CINQAIR® (reslizumab) Injection – About CINQAIR